Study protocol : a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE) / V. N. Leukes, J. Hella, I. Sabi, M. Cossa, C. Khosa, B. Erkosar, C. Mangu, E. Siyame, B. Mtafya, A. Lwilla, S. Viegas, C. Madeira, A. Machiana, J. Ribeiro, A. L. Garcia-Basteiro, F. Riess, D. Elísio, M. Sasamalo, G. Mhalu, C. M. Denkinger, M. D. M. Castro, S. Bashir, S. G. Schumacher, E. Tagliani, A. Malhotra, D. Dowdy, C. Schacht, J. Buech, D. Nguenha, N. Ntinginya, M. Ruhwald, A. Penn-Nicholson, K. Kranzer & TB-CAPT Consortium
In 2020, the WHO-approved Molbio Truenat platform and MTB assays to detect Mycobacterium tuberculosis complex (MTB) and resistance to rifampicin directly on sputum specimens. This primary health care center-based trial in Mozambique and Tanzania investigates the effect of Truenat platform/MTB assays (intervention arm) combined with rapid communication of results compared to standard of care on TB diagnosis and treatment initiation for microbiologically confirmed TB at 7 days from enrolment..
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
19 January 2024 2024 |
---|---|
Erschienen: |
19 January 2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:24 |
---|---|
Enthalten in: |
BMC infectious diseases - 24(2024), 1, Artikel-ID 107, Seite 1-12 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Leukes, Vinzeigh [VerfasserIn] |
---|
Links: |
---|
Themen: |
Clinical trial |
---|
Anmerkungen: |
Gesehen am 19.03.2024 |
---|
Umfang: |
Illustrationen 12 |
---|
doi: |
10.1186/s12879-023-08876-8 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
1883796652 |
---|
LEADER | 01000caa a2200265 4500 | ||
---|---|---|---|
001 | 1883796652 | ||
003 | DE-627 | ||
005 | 20240325174237.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240319s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12879-023-08876-8 |2 doi | |
035 | |a (DE-627)1883796652 | ||
035 | |a (DE-599)KXP1883796652 | ||
040 | |a DE-627 |b ger |c DE-627 |e rda | ||
041 | |a eng | ||
100 | 1 | |a Leukes, Vinzeigh |e verfasserin |0 (DE-588)1323895507 |0 (DE-627)1883799961 |4 aut | |
245 | 1 | 0 | |a Study protocol |b a pragmatic, cluster-randomized controlled trial to evaluate the effect of implementation of the Truenat platform/MTB assays at primary health care clinics in Mozambique and Tanzania (TB-CAPT CORE) |c V. N. Leukes, J. Hella, I. Sabi, M. Cossa, C. Khosa, B. Erkosar, C. Mangu, E. Siyame, B. Mtafya, A. Lwilla, S. Viegas, C. Madeira, A. Machiana, J. Ribeiro, A. L. Garcia-Basteiro, F. Riess, D. Elísio, M. Sasamalo, G. Mhalu, C. M. Denkinger, M. D. M. Castro, S. Bashir, S. G. Schumacher, E. Tagliani, A. Malhotra, D. Dowdy, C. Schacht, J. Buech, D. Nguenha, N. Ntinginya, M. Ruhwald, A. Penn-Nicholson, K. Kranzer & TB-CAPT Consortium |
264 | 1 | |c 19 January 2024 | |
300 | |b Illustrationen | ||
300 | |a 12 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 19.03.2024 | ||
520 | |a In 2020, the WHO-approved Molbio Truenat platform and MTB assays to detect Mycobacterium tuberculosis complex (MTB) and resistance to rifampicin directly on sputum specimens. This primary health care center-based trial in Mozambique and Tanzania investigates the effect of Truenat platform/MTB assays (intervention arm) combined with rapid communication of results compared to standard of care on TB diagnosis and treatment initiation for microbiologically confirmed TB at 7 days from enrolment. | ||
650 | 4 | |a Clinical trial | |
650 | 4 | |a Diagnostics | |
650 | 4 | |a Efficacy | |
650 | 4 | |a Implementation | |
650 | 4 | |a Truenat | |
650 | 4 | |a Tuberculosis | |
700 | 1 | |a Hella, J. |e verfasserin |4 aut | |
700 | 1 | |a Sabi, I. |e verfasserin |4 aut | |
700 | 1 | |a Cossa, M. |e verfasserin |4 aut | |
700 | 1 | |a Khosa, C. |e verfasserin |4 aut | |
700 | 1 | |a Erkosar, B. |e verfasserin |4 aut | |
700 | 1 | |a Mangu, C. |e verfasserin |4 aut | |
700 | 1 | |a Siyame, E. |e verfasserin |4 aut | |
700 | 1 | |a Mtafya, B. |e verfasserin |4 aut | |
700 | 1 | |a Lwilla, A. |e verfasserin |4 aut | |
700 | 1 | |a Viegas, S. |e verfasserin |4 aut | |
700 | 1 | |a Madeira, C. |e verfasserin |4 aut | |
700 | 1 | |a Machiana, A. |e verfasserin |4 aut | |
700 | 1 | |a Ribeiro, J. |e verfasserin |4 aut | |
700 | 1 | |a Garcia-Basteiro, A. L. |e verfasserin |4 aut | |
700 | 1 | |a Riess, F. |e verfasserin |4 aut | |
700 | 1 | |a Elísio, D. |e verfasserin |4 aut | |
700 | 1 | |a Sasamalo, M. |e verfasserin |4 aut | |
700 | 1 | |a Mhalu, G. |e verfasserin |4 aut | |
700 | 1 | |a Denkinger, Claudia M. |d 1978- |e verfasserin |0 (DE-588)131597701 |0 (DE-627)511279469 |0 (DE-576)298613727 |4 aut | |
700 | 1 | |a Castro, María del Mar |e verfasserin |0 (DE-588)1205288600 |0 (DE-627)1690875658 |4 aut | |
700 | 1 | |a Bashir, S. |e verfasserin |4 aut | |
700 | 1 | |a Schumacher, S. G. |e verfasserin |4 aut | |
700 | 1 | |a Tagliani, E. |e verfasserin |4 aut | |
700 | 1 | |a Malhotra, A. |e verfasserin |4 aut | |
700 | 1 | |a Dowdy, D. |e verfasserin |4 aut | |
700 | 1 | |a Schacht, C. |e verfasserin |4 aut | |
700 | 1 | |a Buech, J. |e verfasserin |4 aut | |
700 | 1 | |a Nguenha, D. |e verfasserin |4 aut | |
700 | 1 | |a Ntinginya, N. |e verfasserin |4 aut | |
700 | 1 | |a Ruhwald, M. |e verfasserin |4 aut | |
700 | 1 | |a Penn-Nicholson, A. |e verfasserin |4 aut | |
700 | 1 | |a Kranzer, K. |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t BMC infectious diseases |d London : BioMed Central, 2001 |g 24(2024), 1, Artikel-ID 107, Seite 1-12 |h Online-Ressource |w (DE-627)326645381 |w (DE-600)2041550-3 |w (DE-576)107014793 |x 1471-2334 |7 nnns |
773 | 1 | 8 | |g volume:24 |g year:2024 |g number:1 |g elocationid:107 |g pages:1-12 |g extent:12 |
856 | 4 | 0 | |u https://doi.org/10.1186/s12879-023-08876-8 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
856 | 4 | 0 | |u https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08876-8 |x Verlag |z kostenfrei |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ILN_2013 | ||
912 | |a ISIL_DE-16-250 | ||
912 | |a SYSFLAG_1 | ||
912 | |a GBV_KXP | ||
912 | |a GBV_ILN_11 | ||
912 | |a GBV_ILN_20 | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_23 | ||
912 | |a GBV_ILN_24 | ||
912 | |a GBV_ILN_31 | ||
912 | |a GBV_ILN_39 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_60 | ||
912 | |a GBV_ILN_62 | ||
912 | |a GBV_ILN_63 | ||
912 | |a GBV_ILN_65 | ||
912 | |a GBV_ILN_69 | ||
912 | |a GBV_ILN_73 | ||
912 | |a GBV_ILN_74 | ||
912 | |a GBV_ILN_95 | ||
912 | |a GBV_ILN_105 | ||
912 | |a GBV_ILN_110 | ||
912 | |a GBV_ILN_151 | ||
912 | |a GBV_ILN_161 | ||
912 | |a GBV_ILN_170 | ||
912 | |a GBV_ILN_206 | ||
912 | |a GBV_ILN_213 | ||
912 | |a GBV_ILN_230 | ||
912 | |a GBV_ILN_285 | ||
912 | |a GBV_ILN_293 | ||
912 | |a GBV_ILN_602 | ||
912 | |a GBV_ILN_702 | ||
912 | |a GBV_ILN_2001 | ||
912 | |a GBV_ILN_2003 | ||
912 | |a GBV_ILN_2005 | ||
912 | |a GBV_ILN_2006 | ||
912 | |a GBV_ILN_2008 | ||
912 | |a GBV_ILN_2009 | ||
912 | |a GBV_ILN_2010 | ||
912 | |a GBV_ILN_2011 | ||
912 | |a GBV_ILN_2014 | ||
912 | |a GBV_ILN_2015 | ||
912 | |a GBV_ILN_2020 | ||
912 | |a GBV_ILN_2021 | ||
912 | |a GBV_ILN_2025 | ||
912 | |a GBV_ILN_2031 | ||
912 | |a GBV_ILN_2038 | ||
912 | |a GBV_ILN_2044 | ||
912 | |a GBV_ILN_2048 | ||
912 | |a GBV_ILN_2050 | ||
912 | |a GBV_ILN_2055 | ||
912 | |a GBV_ILN_2056 | ||
912 | |a GBV_ILN_2057 | ||
912 | |a GBV_ILN_2061 | ||
912 | |a GBV_ILN_2111 | ||
912 | |a GBV_ILN_2113 | ||
912 | |a GBV_ILN_2190 | ||
912 | |a GBV_ILN_2446 | ||
912 | |a GBV_ILN_4012 | ||
912 | |a GBV_ILN_4037 | ||
912 | |a GBV_ILN_4112 | ||
912 | |a GBV_ILN_4125 | ||
912 | |a GBV_ILN_4126 | ||
912 | |a GBV_ILN_4249 | ||
912 | |a GBV_ILN_4305 | ||
912 | |a GBV_ILN_4306 | ||
912 | |a GBV_ILN_4307 | ||
912 | |a GBV_ILN_4313 | ||
912 | |a GBV_ILN_4322 | ||
912 | |a GBV_ILN_4323 | ||
912 | |a GBV_ILN_4324 | ||
912 | |a GBV_ILN_4325 | ||
912 | |a GBV_ILN_4338 | ||
912 | |a GBV_ILN_4367 | ||
912 | |a GBV_ILN_4700 | ||
912 | |a GBV_ILN_2403 | ||
912 | |a GBV_ILN_2403 | ||
912 | |a ISIL_DE-LFER | ||
951 | |a AR | ||
952 | |d 24 |j 2024 |e 1 |i 107 |h 1-12 |g 12 | ||
980 | |2 2013 |1 01 |x DE-16-250 |b 4501718404 |c 00 |f --%%-- |d --%%-- |e --%%-- |j --%%-- |y l01 |z 19-03-24 | ||
980 | |2 2403 |1 01 |x DE-LFER |b 4510537336 |c 00 |f --%%-- |d --%%-- |e n |j --%%-- |y l01 |z 11-04-24 | ||
981 | |2 2403 |1 01 |x DE-LFER |r https://doi.org/10.1186/s12879-023-08876-8 | ||
981 | |2 2403 |1 01 |x DE-LFER |r https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-023-08876-8 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 00 |s s |a hd2024 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 01 |s s |0 (DE-627)1410508463 |a wissenschaftlicher Artikel (Zeitschrift) | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 02 |s s |a per_33 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 03 |s s |a s_12 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s p |0 (DE-627)1668020653 |a Denkinger, Claudia M. | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1495544966 |a Zentrum für Infektiologie | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s k |0 (DE-627)1416466967 |a Medizinische Fakultät Heidelberg | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 04 |s s |a pos_20 | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s p |0 (DE-627)1690875720 |a Castro, María del Mar | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s k |0 (DE-627)1495544966 |a Zentrum für Infektiologie | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |0 (DE-627)1410501914 |a Verfasser | ||
982 | |2 2013 |1 01 |x DE-16-250 |8 05 |s s |a pos_21 |